1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Hospital-Treated Gram-Negative Infections Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 1.2.2 Klebsiella 1.2.3 Acinetobacter 1.2.4 Coli 1.2.5 cepacia 1.2.6 Pseudomonas 1.2.7 Serratia 1.2.8 Enterobacter 1.2.9 Others 1.3 Market by Application 1.3.1 Global Hospital-Treated Gram-Negative Infections Market Share by Application: 2016 VS 2021 VS 2027 1.3.2 Hospital 1.3.3 Lab 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Hospital-Treated Gram-Negative Infections Market Perspective (2016-2027) 2.2 Hospital-Treated Gram-Negative Infections Growth Trends by Regions 2.2.1 Hospital-Treated Gram-Negative Infections Market Size by Regions: 2016 VS 2021 VS 2027 2.2.2 Hospital-Treated Gram-Negative Infections Historic Market Share by Regions (2016-2021) 2.2.3 Hospital-Treated Gram-Negative Infections Forecasted Market Size by Regions (2022-2027) 2.3 Hospital-Treated Gram-Negative Infections Industry Dynamic 2.3.1 Hospital-Treated Gram-Negative Infections Market Trends 2.3.2 Hospital-Treated Gram-Negative Infections Market Drivers 2.3.3 Hospital-Treated Gram-Negative Infections Market Challenges 2.3.4 Hospital-Treated Gram-Negative Infections Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Hospital-Treated Gram-Negative Infections Players by Revenue 3.1.1 Global Top Hospital-Treated Gram-Negative Infections Players by Revenue (2016-2021) 3.1.2 Global Hospital-Treated Gram-Negative Infections Revenue Market Share by Players (2016-2021) 3.2 Global Hospital-Treated Gram-Negative Infections Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by Hospital-Treated Gram-Negative Infections Revenue 3.4 Global Hospital-Treated Gram-Negative Infections Market Concentration Ratio 3.4.1 Global Hospital-Treated Gram-Negative Infections Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Hospital-Treated Gram-Negative Infections Revenue in 2020 3.5 Hospital-Treated Gram-Negative Infections Key Players Head office and Area Served 3.6 Key Players Hospital-Treated Gram-Negative Infections Product Solution and Service 3.7 Date of Enter into Hospital-Treated Gram-Negative Infections Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Hospital-Treated Gram-Negative Infections Breakdown Data by Type 4.1 Global Hospital-Treated Gram-Negative Infections Historic Market Size by Type (2016-2021) 4.2 Global Hospital-Treated Gram-Negative Infections Forecasted Market Size by Type (2022-2027) 5 Hospital-Treated Gram-Negative Infections Breakdown Data by Application 5.1 Global Hospital-Treated Gram-Negative Infections Historic Market Size by Application (2016-2021) 5.2 Global Hospital-Treated Gram-Negative Infections Forecasted Market Size by Application (2022-2027) 6 North America 6.1 North America Hospital-Treated Gram-Negative Infections Market Size (2016-2027) 6.2 North America Hospital-Treated Gram-Negative Infections Market Size by Type 6.2.1 North America Hospital-Treated Gram-Negative Infections Market Size by Type (2016-2021) 6.2.2 North America Hospital-Treated Gram-Negative Infections Market Size by Type (2022-2027) 6.2.3 North America Hospital-Treated Gram-Negative Infections Market Size by Type (2016-2027) 6.3 North America Hospital-Treated Gram-Negative Infections Market Size by Application 6.3.1 North America Hospital-Treated Gram-Negative Infections Market Size by Application (2016-2021) 6.3.2 North America Hospital-Treated Gram-Negative Infections Market Size by Application (2022-2027) 6.3.3 North America Hospital-Treated Gram-Negative Infections Market Size by Application (2016-2027) 6.4 North America Hospital-Treated Gram-Negative Infections Market Size by Country 6.4.1 North America Hospital-Treated Gram-Negative Infections Market Size by Country (2016-2021) 6.4.2 North America Hospital-Treated Gram-Negative Infections Market Size by Country (2022-2027) 6.4.3 United States 6.4.3 Canada 7 Europe 7.1 Europe Hospital-Treated Gram-Negative Infections Market Size (2016-2027) 7.2 Europe Hospital-Treated Gram-Negative Infections Market Size by Type 7.2.1 Europe Hospital-Treated Gram-Negative Infections Market Size by Type (2016-2021) 7.2.2 Europe Hospital-Treated Gram-Negative Infections Market Size by Type (2022-2027) 7.2.3 Europe Hospital-Treated Gram-Negative Infections Market Size by Type (2016-2027) 7.3 Europe Hospital-Treated Gram-Negative Infections Market Size by Application 7.3.1 Europe Hospital-Treated Gram-Negative Infections Market Size by Application (2016-2021) 7.3.2 Europe Hospital-Treated Gram-Negative Infections Market Size by Application (2022-2027) 7.3.3 Europe Hospital-Treated Gram-Negative Infections Market Size by Application (2016-2027) 7.4 Europe Hospital-Treated Gram-Negative Infections Market Size by Country 7.4.1 Europe Hospital-Treated Gram-Negative Infections Market Size by Country (2016-2021) 7.4.2 Europe Hospital-Treated Gram-Negative Infections Market Size by Country (2022-2027) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic 8 Asia-Pacific 8.1 Asia-Pacific Hospital-Treated Gram-Negative Infections Market Size (2016-2027) 8.2 Asia-Pacific Hospital-Treated Gram-Negative Infections Market Size by Type 8.2.1 Asia-Pacific Hospital-Treated Gram-Negative Infections Market Size by Type (2016-2021) 8.2.2 Asia-Pacific Hospital-Treated Gram-Negative Infections Market Size by Type (2022-2027) 8.2.3 Asia-Pacific Hospital-Treated Gram-Negative Infections Market Size by Type (2016-2027) 8.3 Asia-Pacific Hospital-Treated Gram-Negative Infections Market Size by Application 8.3.1 Asia-Pacific Hospital-Treated Gram-Negative Infections Market Size by Application (2016-2021) 8.3.2 Asia-Pacific Hospital-Treated Gram-Negative Infections Market Size by Application (2022-2027) 8.3.3 Asia-Pacific Hospital-Treated Gram-Negative Infections Market Size by Application (2016-2027) 8.4 Asia-Pacific Hospital-Treated Gram-Negative Infections Market Size by Region 8.4.1 Asia-Pacific Hospital-Treated Gram-Negative Infections Market Size by Region (2016-2021) 8.4.2 Asia-Pacific Hospital-Treated Gram-Negative Infections Market Size by Region (2022-2027) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Hospital-Treated Gram-Negative Infections Market Size (2016-2027) 9.2 Latin America Hospital-Treated Gram-Negative Infections Market Size by Type 9.2.1 Latin America Hospital-Treated Gram-Negative Infections Market Size by Type (2016-2021) 9.2.2 Latin America Hospital-Treated Gram-Negative Infections Market Size by Type (2022-2027) 9.2.3 Latin America Hospital-Treated Gram-Negative Infections Market Size by Type (2016-2027) 9.3 Latin America Hospital-Treated Gram-Negative Infections Market Size by Application 9.3.1 Latin America Hospital-Treated Gram-Negative Infections Market Size by Application (2016-2021) 9.3.2 Latin America Hospital-Treated Gram-Negative Infections Market Size by Application (2022-2027) 9.3.3 Latin America Hospital-Treated Gram-Negative Infections Market Size by Application (2016-2027) 9.4 Latin America Hospital-Treated Gram-Negative Infections Market Size by Country 9.4.1 Latin America Hospital-Treated Gram-Negative Infections Market Size by Country (2016-2021) 9.4.2 Latin America Hospital-Treated Gram-Negative Infections Market Size by Country (2022-2027) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Hospital-Treated Gram-Negative Infections Market Size (2016-2027) 10.2 Middle East & Africa Hospital-Treated Gram-Negative Infections Market Size by Type 10.2.1 Middle East & Africa Hospital-Treated Gram-Negative Infections Market Size by Type (2016-2021) 10.2.2 Middle East & Africa Hospital-Treated Gram-Negative Infections Market Size by Type (2022-2027) 10.2.3 Middle East & Africa Hospital-Treated Gram-Negative Infections Market Size by Type (2016-2027) 10.3 Middle East & Africa Hospital-Treated Gram-Negative Infections Market Size by Application 10.3.1 Middle East & Africa Hospital-Treated Gram-Negative Infections Market Size by Application (2016-2021) 10.3.2 Middle East & Africa Hospital-Treated Gram-Negative Infections Market Size by Application (2022-2027) 10.3.3 Middle East & Africa Hospital-Treated Gram-Negative Infections Market Size by Application (2016-2027) 10.4 Middle East & Africa Hospital-Treated Gram-Negative Infections Market Size by Country 10.4.1 Middle East & Africa Hospital-Treated Gram-Negative Infections Market Size by Country (2016-2021) 10.4.2 Middle East & Africa Hospital-Treated Gram-Negative Infections Market Size by Country (2022-2027) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 Merck 11.1.1 Merck Company Details 11.1.2 Merck Business Overview 11.1.3 Merck Hospital-Treated Gram-Negative Infections Introduction 11.1.4 Merck Revenue in Hospital-Treated Gram-Negative Infections Business (2016-2021) 11.1.5 Merck Recent Development 11.2 Pfizer 11.2.1 Pfizer Company Details 11.2.2 Pfizer Business Overview 11.2.3 Pfizer Hospital-Treated Gram-Negative Infections Introduction 11.2.4 Pfizer Revenue in Hospital-Treated Gram-Negative Infections Business (2016-2021) 11.2.5 Pfizer Recent Development 11.3 AstraZeneca 11.3.1 AstraZeneca Company Details 11.3.2 AstraZeneca Business Overview 11.3.3 AstraZeneca Hospital-Treated Gram-Negative Infections Introduction 11.3.4 AstraZeneca Revenue in Hospital-Treated Gram-Negative Infections Business (2016-2021) 11.3.5 AstraZeneca Recent Development 11.4 Abbott 11.4.1 Abbott Company Details 11.4.2 Abbott Business Overview 11.4.3 Abbott Hospital-Treated Gram-Negative Infections Introduction 11.4.4 Abbott Revenue in Hospital-Treated Gram-Negative Infections Business (2016-2021) 11.4.5 Abbott Recent Development 11.5 Lupin Pharmaceuticals 11.5.1 Lupin Pharmaceuticals Company Details 11.5.2 Lupin Pharmaceuticals Business Overview 11.5.3 Lupin Pharmaceuticals Hospital-Treated Gram-Negative Infections Introduction 11.5.4 Lupin Pharmaceuticals Revenue in Hospital-Treated Gram-Negative Infections Business (2016-2021) 11.5.5 Lupin Pharmaceuticals Recent Development 11.6 Istituto lusofarmaco d’italia 11.6.1 Istituto lusofarmaco d’italia Company Details 11.6.2 Istituto lusofarmaco d’italia Business Overview 11.6.3 Istituto lusofarmaco d’italia Hospital-Treated Gram-Negative Infections Introduction 11.6.4 Istituto lusofarmaco d’italia Revenue in Hospital-Treated Gram-Negative Infections Business (2016-2021) 11.6.5 Istituto lusofarmaco d’italia Recent Development 11.7 Adelco S.A 11.7.1 Adelco S.A Company Details 11.7.2 Adelco S.A Business Overview 11.7.3 Adelco S.A Hospital-Treated Gram-Negative Infections Introduction 11.7.4 Adelco S.A Revenue in Hospital-Treated Gram-Negative Infections Business (2016-2021) 11.7.5 Adelco S.A Recent Development 11.8 Zhejiang yuntao biotechnology co., Ltd 11.8.1 Zhejiang yuntao biotechnology co., Ltd Company Details 11.8.2 Zhejiang yuntao biotechnology co., Ltd Business Overview 11.8.3 Zhejiang yuntao biotechnology co., Ltd Hospital-Treated Gram-Negative Infections Introduction 11.8.4 Zhejiang yuntao biotechnology co., Ltd Revenue in Hospital-Treated Gram-Negative Infections Business (2016-2021) 11.8.5 Zhejiang yuntao biotechnology co., Ltd Recent Development 11.9 Alcon Laboratories 11.9.1 Alcon Laboratories Company Details 11.9.2 Alcon Laboratories Business Overview 11.9.3 Alcon Laboratories Hospital-Treated Gram-Negative Infections Introduction 11.9.4 Alcon Laboratories Revenue in Hospital-Treated Gram-Negative Infections Business (2016-2021) 11.9.5 Alcon Laboratories Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Hospital-Treated Gram-Negative Infections Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027 Table 2. Key Players of Klebsiella Table 3. Key Players of Acinetobacter Table 4. Key Players of Coli Table 5. Key Players of cepacia Table 6. Key Players of Pseudomonas Table 7. Key Players of Serratia Table 8. Key Players of Enterobacter Table 9. Key Players of Others Table 10. Global Hospital-Treated Gram-Negative Infections Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027 Table 11. Global Hospital-Treated Gram-Negative Infections Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027 Table 12. Global Hospital-Treated Gram-Negative Infections Market Size by Regions (2016-2021) & (US$ Million) Table 13. Global Hospital-Treated Gram-Negative Infections Market Share by Regions (2016-2021) Table 14. Global Hospital-Treated Gram-Negative Infections Forecasted Market Size by Regions (2022-2027) & (US$ Million) Table 15. Global Hospital-Treated Gram-Negative Infections Market Share by Regions (2022-2027) Table 16. Hospital-Treated Gram-Negative Infections Market Trends Table 17. Hospital-Treated Gram-Negative Infections Market Drivers Table 18. Hospital-Treated Gram-Negative Infections Market Challenges Table 19. Hospital-Treated Gram-Negative Infections Market Restraints Table 20. Global Hospital-Treated Gram-Negative Infections Revenue by Players (2016-2021) & (US$ Million) Table 21. Global Hospital-Treated Gram-Negative Infections Market Share by Players (2016-2021) Table 22. Global Top Hospital-Treated Gram-Negative Infections Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hospital-Treated Gram-Negative Infections as of 2020) Table 23. Ranking of Global Top Hospital-Treated Gram-Negative Infections Companies by Revenue (US$ Million) in 2020 Table 24. Global 5 Largest Players Market Share by Hospital-Treated Gram-Negative Infections Revenue (CR5 and HHI) & (2016-2021) Table 25. Key Players Headquarters and Area Served Table 26. Key Players Hospital-Treated Gram-Negative Infections Product Solution and Service Table 27. Date of Enter into Hospital-Treated Gram-Negative Infections Market Table 28. Mergers & Acquisitions, Expansion Plans Table 29. Global Hospital-Treated Gram-Negative Infections Market Size by Type (2016-2021) (US$ Million) Table 30. Global Hospital-Treated Gram-Negative Infections Revenue Market Share by Type (2016-2021) Table 31. Global Hospital-Treated Gram-Negative Infections Forecasted Market Size by Type (2022-2027) (US$ Million) Table 32. Global Hospital-Treated Gram-Negative Infections Revenue Market Share by Type (2022-2027) & (US$ Million) Table 33. Global Hospital-Treated Gram-Negative Infections Market Size Share by Application (2016-2021) & (US$ Million) Table 34. Global Hospital-Treated Gram-Negative Infections Revenue Market Share by Application (2016-2021) Table 35. Global Hospital-Treated Gram-Negative Infections Forecasted Market Size by Application (2022-2027) (US$ Million) Table 36. Global Hospital-Treated Gram-Negative Infections Revenue Market Share by Application (2022-2027) & (US$ Million) Table 37. North America Hospital-Treated Gram-Negative Infections Market Size by Type (2016-2021) (US$ Million) Table 38. North America Hospital-Treated Gram-Negative Infections Market Size by Type (2022-2027) & (US$ Million) Table 39. North America Hospital-Treated Gram-Negative Infections Market Size by Application (2016-2021) (US$ Million) Table 40. North America Hospital-Treated Gram-Negative Infections Market Size by Application (2022-2027) & (US$ Million) Table 41. North America Hospital-Treated Gram-Negative Infections Market Size by Country (2016-2021) & (US$ Million) Table 42. North America Hospital-Treated Gram-Negative Infections Market Size by Country (2022-2027) & (US$ Million) Table 43. Europe Hospital-Treated Gram-Negative Infections Market Size by Type (2016-2021) (US$ Million) Table 44. Europe Hospital-Treated Gram-Negative Infections Market Size by Type (2022-2027) & (US$ Million) Table 45. Europe Hospital-Treated Gram-Negative Infections Market Size by Application (2016-2021) (US$ Million) Table 46. Europe Hospital-Treated Gram-Negative Infections Market Size by Application (2022-2027) & (US$ Million) Table 47. Europe Hospital-Treated Gram-Negative Infections Market Size by Country (2016-2021) & (US$ Million) Table 48. Europe Hospital-Treated Gram-Negative Infections Market Size by Country (2022-2027) & (US$ Million) Table 49. Asia-Pacific Hospital-Treated Gram-Negative Infections Market Size by Type (2016-2021) (US$ Million) Table 50. Asia-Pacific Hospital-Treated Gram-Negative Infections Market Size by Type (2022-2027) & (US$ Million) Table 51. Asia-Pacific Hospital-Treated Gram-Negative Infections Market Size by Application (2016-2021) (US$ Million) Table 52. Asia-Pacific Hospital-Treated Gram-Negative Infections Market Size by Application (2022-2027) & (US$ Million) Table 53. Asia-Pacific Hospital-Treated Gram-Negative Infections Market Size by Region (2016-2021) & (US$ Million) Table 54. Asia-Pacific Hospital-Treated Gram-Negative Infections Market Size by Region (2022-2027) & (US$ Million) Table 55. Latin America Hospital-Treated Gram-Negative Infections Market Size by Type (2016-2021) (US$ Million) Table 56. Latin America Hospital-Treated Gram-Negative Infections Market Size by Type (2022-2027) & (US$ Million) Table 57. Latin America Hospital-Treated Gram-Negative Infections Market Size by Application (2016-2021) (US$ Million) Table 58. Latin America Hospital-Treated Gram-Negative Infections Market Size by Application (2022-2027) & (US$ Million) Table 59. Latin America Hospital-Treated Gram-Negative Infections Market Size by Country (2016-2021) & (US$ Million) Table 60. Latin America Hospital-Treated Gram-Negative Infections Market Size by Country (2022-2027) & (US$ Million) Table 61. Middle East & Africa Hospital-Treated Gram-Negative Infections Market Size by Type (2016-2021) (US$ Million) Table 62. Middle East & Africa Hospital-Treated Gram-Negative Infections Market Size by Type (2022-2027) & (US$ Million) Table 63. Middle East & Africa Hospital-Treated Gram-Negative Infections Market Size by Application (2016-2021) (US$ Million) Table 64. Middle East & Africa Hospital-Treated Gram-Negative Infections Market Size by Application (2022-2027) & (US$ Million) Table 65. Middle East & Africa Hospital-Treated Gram-Negative Infections Market Size by Country (2016-2021) & (US$ Million) Table 66. Middle East & Africa Hospital-Treated Gram-Negative Infections Market Size by Country (2022-2027) & (US$ Million) Table 67. Merck Company Details Table 68. Merck Business Overview Table 69. Merck Hospital-Treated Gram-Negative Infections Product Table 70. Merck Revenue in Hospital-Treated Gram-Negative Infections Business (2016-2021) & (US$ Million) Table 71. Merck Recent Development Table 72. Pfizer Company Details Table 73. Pfizer Business Overview Table 74. Pfizer Hospital-Treated Gram-Negative Infections Product Table 75. Pfizer Revenue in Hospital-Treated Gram-Negative Infections Business (2016-2021) & (US$ Million) Table 76. Pfizer Recent Development Table 77. AstraZeneca Company Details Table 78. AstraZeneca Business Overview Table 79. AstraZeneca Hospital-Treated Gram-Negative Infections Product Table 80. AstraZeneca Revenue in Hospital-Treated Gram-Negative Infections Business (2016-2021) & (US$ Million) Table 81. AstraZeneca Recent Development Table 82. Abbott Company Details Table 83. Abbott Business Overview Table 84. Abbott Hospital-Treated Gram-Negative Infections Product Table 85. Abbott Revenue in Hospital-Treated Gram-Negative Infections Business (2016-2021) & (US$ Million) Table 86. Abbott Recent Development Table 87. Lupin Pharmaceuticals Company Details Table 88. Lupin Pharmaceuticals Business Overview Table 89. Lupin Pharmaceuticals Hospital-Treated Gram-Negative Infections Product Table 90. Lupin Pharmaceuticals Revenue in Hospital-Treated Gram-Negative Infections Business (2016-2021) & (US$ Million) Table 91. Lupin Pharmaceuticals Recent Development Table 92. Istituto lusofarmaco d’italia Company Details Table 93. Istituto lusofarmaco d’italia Business Overview Table 94. Istituto lusofarmaco d’italia Hospital-Treated Gram-Negative Infections Product Table 95. Istituto lusofarmaco d’italia Revenue in Hospital-Treated Gram-Negative Infections Business (2016-2021) & (US$ Million) Table 96. Istituto lusofarmaco d’italia Recent Development Table 97. Adelco S.A Company Details Table 98. Adelco S.A Business Overview Table 99. Adelco S.A Hospital-Treated Gram-Negative Infections Product Table 100. Adelco S.A Revenue in Hospital-Treated Gram-Negative Infections Business (2016-2021) & (US$ Million) Table 101. Adelco S.A Recent Development Table 102. Zhejiang yuntao biotechnology co., Ltd Company Details Table 103. Zhejiang yuntao biotechnology co., Ltd Business Overview Table 104. Zhejiang yuntao biotechnology co., Ltd Revenue in Hospital-Treated Gram-Negative Infections Business (2016-2021) & (US$ Million) Table 105. Zhejiang yuntao biotechnology co., Ltd Recent Development Table 106. Alcon Laboratories Company Details Table 107. Alcon Laboratories Business Overview Table 108. Alcon Laboratories Hospital-Treated Gram-Negative Infections Product Table 109. Alcon Laboratories Revenue in Hospital-Treated Gram-Negative Infections Business (2016-2021) & (US$ Million) Table 110. Alcon Laboratories Recent Development Table 111. Research Programs/Design for This Report Table 112. Key Data Information from Secondary Sources Table 113. Key Data Information from Primary Sources List of Figures Figure 1. Global Hospital-Treated Gram-Negative Infections Market Share by Type: 2020 VS 2027 Figure 2. Klebsiella Features Figure 3. Acinetobacter Features Figure 4. Coli Features Figure 5. cepacia Features Figure 6. Pseudomonas Features Figure 7. Serratia Features Figure 8. Enterobacter Features Figure 9. Others Features Figure 10. Global Hospital-Treated Gram-Negative Infections Market Share by Application: 2020 VS 2027 Figure 11. Hospital Case Studies Figure 12. Lab Case Studies Figure 13. Hospital-Treated Gram-Negative Infections Report Years Considered Figure 14. Global Hospital-Treated Gram-Negative Infections Market Size (US$ Million), Year-over-Year: 2016-2027 Figure 15. Global Hospital-Treated Gram-Negative Infections Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 16. Global Hospital-Treated Gram-Negative Infections Market Share by Regions: 2020 VS 2027 Figure 17. Global Hospital-Treated Gram-Negative Infections Market Share by Regions (2022-2027) Figure 18. Global Hospital-Treated Gram-Negative Infections Market Share by Players in 2020 Figure 19. Global Top Hospital-Treated Gram-Negative Infections Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hospital-Treated Gram-Negative Infections as of 2020 Figure 20. The Top 10 and 5 Players Market Share by Hospital-Treated Gram-Negative Infections Revenue in 2020 Figure 21. Global Hospital-Treated Gram-Negative Infections Revenue Market Share by Type (2016-2021) Figure 22. Global Hospital-Treated Gram-Negative Infections Revenue Market Share by Type (2022-2027) Figure 23. North America Hospital-Treated Gram-Negative Infections Market Size YoY Growth (2016-2027) & (US$ Million) Figure 24. North America Hospital-Treated Gram-Negative Infections Market Share by Type (2016-2027) Figure 25. North America Hospital-Treated Gram-Negative Infections Market Share by Application (2016-2027) Figure 26. North America Hospital-Treated Gram-Negative Infections Market Share by Country (2016-2027) Figure 27. United States Hospital-Treated Gram-Negative Infections Market Size YoY Growth (2016-2027) & (US$ Million) Figure 28. Canada Hospital-Treated Gram-Negative Infections Market Size YoY Growth (2016-2027) & (US$ Million) Figure 29. Europe Hospital-Treated Gram-Negative Infections Market Size YoY Growth (2016-2027) & (US$ Million) Figure 30. Europe Hospital-Treated Gram-Negative Infections Market Share by Type (2016-2027) Figure 31. Europe Hospital-Treated Gram-Negative Infections Market Share by Application (2016-2027) Figure 32. Europe Hospital-Treated Gram-Negative Infections Market Share by Country (2016-2027) Figure 33. Germany Hospital-Treated Gram-Negative Infections Market Size YoY Growth (2016-2027) & (US$ Million) Figure 34. France Hospital-Treated Gram-Negative Infections Market Size YoY Growth (2016-2027) & (US$ Million) Figure 35. U.K. Hospital-Treated Gram-Negative Infections Market Size YoY Growth (2016-2027) & (US$ Million) Figure 36. Italy Hospital-Treated Gram-Negative Infections Market Size YoY Growth (2016-2027) & (US$ Million) Figure 37. Russia Hospital-Treated Gram-Negative Infections Market Size YoY Growth (2016-2027) & (US$ Million) Figure 38. Nordic Hospital-Treated Gram-Negative Infections Market Size YoY Growth (2016-2027) & (US$ Million) Figure 39. Asia-Pacific Hospital-Treated Gram-Negative Infections Market Size YoY Growth (2016-2027) & (US$ Million) Figure 40. Asia-Pacific Hospital-Treated Gram-Negative Infections Market Share by Type (2016-2027) Figure 41. Asia-Pacific Hospital-Treated Gram-Negative Infections Market Share by Application (2016-2027) Figure 42. Asia-Pacific Hospital-Treated Gram-Negative Infections Market Share by Region (2016-2027) Figure 43. China Hospital-Treated Gram-Negative Infections Market Size YoY Growth (2016-2027) & (US$ Million) Figure 44. Japan Hospital-Treated Gram-Negative Infections Market Size YoY Growth (2016-2027) & (US$ Million) Figure 45. South Korea Hospital-Treated Gram-Negative Infections Market Size YoY Growth (2016-2027) & (US$ Million) Figure 46. Southeast Asia Hospital-Treated Gram-Negative Infections Market Size YoY Growth (2016-2027) & (US$ Million) Figure 47. India Hospital-Treated Gram-Negative Infections Market Size YoY Growth (2016-2027) & (US$ Million) Figure 48. Australia Hospital-Treated Gram-Negative Infections Market Size YoY Growth (2016-2027) & (US$ Million) Figure 49. Latin America Hospital-Treated Gram-Negative Infections Market Size YoY Growth (2016-2027) & (US$ Million) Figure 50. Latin America Hospital-Treated Gram-Negative Infections Market Share by Type (2016-2027) Figure 51. Latin America Hospital-Treated Gram-Negative Infections Market Share by Application (2016-2027) Figure 52. Latin America Hospital-Treated Gram-Negative Infections Market Share by Country (2016-2027) Figure 53. Mexico Hospital-Treated Gram-Negative Infections Market Size YoY Growth (2016-2027) & (US$ Million) Figure 54. Brazil Hospital-Treated Gram-Negative Infections Market Size YoY Growth (2016-2027) & (US$ Million) Figure 55. Middle East & Africa Hospital-Treated Gram-Negative Infections Market Size YoY Growth (2016-2027) & (US$ Million) Figure 56. Middle East & Africa Hospital-Treated Gram-Negative Infections Market Share by Type (2016-2027) Figure 57. Middle East & Africa Hospital-Treated Gram-Negative Infections Market Share by Application (2016-2027) Figure 58. Middle East & Africa Hospital-Treated Gram-Negative Infections Market Share by Country (2016-2027) Figure 59. Turkey Hospital-Treated Gram-Negative Infections Market Size YoY Growth (2016-2027) & (US$ Million) Figure 60. Saudi Arabia Hospital-Treated Gram-Negative Infections Market Size YoY Growth (2016-2027) & (US$ Million) Figure 61. UAE Hospital-Treated Gram-Negative Infections Market Size YoY Growth (2016-2027) & (US$ Million) Figure 62. Merck Revenue Growth Rate in Hospital-Treated Gram-Negative Infections Business (2016-2021) Figure 63. Pfizer Revenue Growth Rate in Hospital-Treated Gram-Negative Infections Business (2016-2021) Figure 64. AstraZeneca Revenue Growth Rate in Hospital-Treated Gram-Negative Infections Business (2016-2021) Figure 65. Abbott Revenue Growth Rate in Hospital-Treated Gram-Negative Infections Business (2016-2021) Figure 66. Lupin Pharmaceuticals Revenue Growth Rate in Hospital-Treated Gram-Negative Infections Business (2016-2021) Figure 67. Istituto lusofarmaco d’italia Revenue Growth Rate in Hospital-Treated Gram-Negative Infections Business (2016-2021) Figure 68. Adelco S.A Revenue Growth Rate in Hospital-Treated Gram-Negative Infections Business (2016-2021) Figure 69. Zhejiang yuntao biotechnology co., Ltd Revenue Growth Rate in Hospital-Treated Gram-Negative Infections Business (2016-2021) Figure 70. Alcon Laboratories Revenue Growth Rate in Hospital-Treated Gram-Negative Infections Business (2016-2021) Figure 71. Bottom-up and Top-down Approaches for This Report Figure 72. Data Triangulation Figure 73. Key Executives Interviewed

Merck Pfizer AstraZeneca Abbott Lupin Pharmaceuticals Istituto lusofarmaco d’italia Adelco S.A Zhejiang yuntao biotechnology co., Ltd Alcon Laboratories